anastrozole has been researched along with Ovarian Diseases in 2 studies
Ovarian Diseases: Pathological processes of the OVARY.
Excerpt | Relevance | Reference |
---|---|---|
"The risk of OFR during AI treatment in breast cancer patients with chemotherapy-induced ovarian function failure is relevant, even beyond 45 years." | 5.46 | Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure. ( de Boer, M; de Graaf, H; de Roos, WK; Erdkamp, FLG; Honkoop, AH; Imholz, ALT; Kitzen, JJEM; Kroep, JR; Linn, SC; Peer, PGM; Seynaeve, CM; Smorenburg, CH; Swinkels, ACP; Tjan-Heijnen, VCG; van den Berkmortel, FWPJ; van der Sangen, MJC; van Hellemond, IEG; Vriens, IJH, 2017) |
"The risk of OFR during AI treatment in breast cancer patients with chemotherapy-induced ovarian function failure is relevant, even beyond 45 years." | 1.46 | Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure. ( de Boer, M; de Graaf, H; de Roos, WK; Erdkamp, FLG; Honkoop, AH; Imholz, ALT; Kitzen, JJEM; Kroep, JR; Linn, SC; Peer, PGM; Seynaeve, CM; Smorenburg, CH; Swinkels, ACP; Tjan-Heijnen, VCG; van den Berkmortel, FWPJ; van der Sangen, MJC; van Hellemond, IEG; Vriens, IJH, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weiner, A | 1 |
D'Andrea, GM | 1 |
van Hellemond, IEG | 1 |
Vriens, IJH | 1 |
Peer, PGM | 1 |
Swinkels, ACP | 1 |
Smorenburg, CH | 1 |
Seynaeve, CM | 1 |
van der Sangen, MJC | 1 |
Kroep, JR | 1 |
de Graaf, H | 1 |
Honkoop, AH | 1 |
Erdkamp, FLG | 1 |
van den Berkmortel, FWPJ | 1 |
Kitzen, JJEM | 1 |
de Boer, M | 1 |
de Roos, WK | 1 |
Linn, SC | 1 |
Imholz, ALT | 1 |
Tjan-Heijnen, VCG | 1 |
2 other studies available for anastrozole and Ovarian Diseases
Article | Year |
---|---|
Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Liver Neoplas | 2018 |
Ovarian Function Recovery During Anastrozole in Breast Cancer Patients With Chemotherapy-Induced Ovarian Function Failure.
Topics: Adult; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Case-Co | 2017 |